Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04746924 |
| Consolidated Lead Sponsor | BeiGene |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 669 participants (ACTUAL) |
| Registered Start Date | 2021-05-24 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Valkyrie Clinical Trials | Los Angeles, CA | Open Hospital Dossier -> |
| Baptist Health Lexington | Lexington, KY | Open Hospital Dossier -> |
| Concord Repatriation General Hospital | Concord, Australia | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.